YEM Search

Plant Summary

Plant Information

TCMBank_ID:	TCMBANKHE004105
ID:	TCMBANKHE004105
植物拉丁名:	Cimicifuga dahurica
功能与主治:	See Cimicifuga foetida ./See Cimicifuga foetida.
药用植物名:	兴安升麻
药用部位:	rhizome
TCM_ID_id:	7117

植物对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN000032	Visnagin	4-Methoxy-7-methyl-5H-furo(3,2-g)(1)-benzopyran-5-one; Spectrum3_001340; DivK1c_006549; EINECS 201-430-3; visnagin; KBio1_001493; SPBio_001751; KBio3_002319; KBio2_004275; 82-57-5; KBioGR_002251; 254932_ALDRICH; KBio2_006843; Desmethoxykhellin; ST5307139; Spectrum2_001796; NSC100593; 4-methoxy-7-methyl-5-pyrano[3,2-f]benzofuranone; 4-methoxy-7-methyl-pyrano[3,2-f][1]benzoxol-5-one; Visnagidin; LMPK02000029; ZINC00120179; MEGxp0_000332; 5H-Furo[3,2-g][1]benzopyran-5-one, 4-methoxy-7-methyl-; 5H-FURO(3,2-g)(1)BENZOPYRAN-5-ONE, 4-METHOXY-7-METHYL-; SDCCGMLS-0066603.P001; BSPBio_003099; 5-19-06-00030 (Beilstein Handbook Reference); Spectrum_001227; NCGC00095626-01; KBio2_001707; SpecPlus_000453; BRN 0234955; KBioSS_001707; 4-methoxy-7-methyl-pyrano[3,2-f]benzofuran-5-one; C09049; SPECTRUM310041; Spectrum5_000351; 4-methoxy-7-methyl-5H-furo [3,2-g][1]-benzopyran-5-one; Oprea1_854963; 4-methoxy-7-methylpyrano[3,2-f][1]benzoxol-5-one; NSC 100593; Visnagine; 4-Methoxy-7-methylfuro(3,2-g)chromen-5-one; 4-Methoxy-7-methyl-5H-furo[3,2-g][1]-benzopyran-5-one; Spectrum4_001766; 5-Methoxy-2-methylfuranochromone	C13H10O4	230.22	CC1=CC(=O)C2=C(O1)C=C3C(=C2OC)C=CO3
TCMBANKIN002068	24-hydroxy-12beta-acetoxy-25,26,27-trinorcycloartan-16,23-dione,3beta-o-alpha-l-arabinopyranoside			620.86
TCMBANKIN004623	visamminol	2,3-dihydro-4-hydroxy-2-7-methyl-5h-furo[3,2-g][1]benzopyran-5-one; 4-hydroxy-2-(2-hydroxypropan-2-yl)-7-methyl-2,3-dihydrofuro[3,2-g]chromen-5-one; AC1NSSV1; Visamminol; CTK8I8620; SCHEMBL15536844; 492-52-4; C17838	C15H16O5	276.28	CC1=CC(=O)C2=C(C3=C(C=C2O1)OC(C3)C(C)(C)O)O
TCMBANKIN011306	cimiside a		C35H56O10	636.8 g/mol	CC1CC2C(OC3(C1C4(C(CC56CC57CCC(C(C7CCC6C4(C3O)C)(C)C)OC8C(C(C(CO8)O)O)O)O)C)O2)C(C)(C)O
TCMBANKIN013872	cimiside f		C36H58O10		CC1CC2C(OC3(C1C4(CCC56CC57CCC(C(C7CCC6C4(C3O)C)(C)C)OC8C(C(C(C(O8)CO)O)O)O)C)O2)C(C)(C)O
TCMBANKIN019841	7,8-didehydrocimigenol 3-o-β-d-xylopyrano-side		C35H54O9
TCMBANKIN025587	acetylcimifugoside		C36H54O10		CC(=O)OC(C)(C)C1C2CCC3C4(CCC56CC57CCC(C(C7CC=C6C4(C(C3(O2)O1)O)C)(C)C)OC8C(C(C(CO8)O)O)O)C
TCMBANKIN026685	heteratisine	NSC295654; Heteratisine; 3328-84-5; STOCK1N-52531	C22H33NO5	391.5 g/mol	CCN1CC2(CCC(C34C2C(C(C31)C5(CCC6CC4C5C(=O)O6)O)O)OC)C
TCMBANKIN030825	cimiside b	AC1L4UM6; AC1Q59N6; 152685-91-1; A-d-xylopyranosyl-; Cimigenol-3-O-xylopyranosyl-3-xylpyranoside; beta-D-Xylopyranoside, (3beta,15alpha,16alpha,23R,24S)-16,23:16,24-diepoxy-15,25-dihydroxy-9,19-cyclolanostan-3-yl 3-O-beta-D-xylopyranosyl-; (7ar,7br,8r,13r,13as)-13-hydroxy-11-(2-hydroxypropan-2-yl)-1,1,7a,8,13a-pentamethyloctadecahydro-10,12a-epoxycyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]oxepin-2-yl 3-o-; A-d-xylopyranoside	C40H64O13	752.9 g/mol	CC1CC2C(OC3(C1C4(CCC56CC57CCC(C(C7CCC6C4(C3O)C)(C)C)OC8C(C(C(CO8)O)OC9C(C(C(CO9)O)O)O)O)C)O2)C(C)(C)O
TCMBANKIN032310	16α,24α-dihydroxy-12β-acetoxy-25,26,27-trinor-16,24-cycloartan-23-one 3β-o-α-l-arabinopy-ranoside		C34H52O10
TCMBANKIN032550	viscidulin b		C17H22O5	306.4 g/mol	CC1C2C(CC(=C)C3CC4C(C3C2OC1=O)(O4)C)OC(=O)C
TCMBANKIN033305	n-3-methyl-2-butenyl urea		C6H12N2O
TCMBANKIN038204	ferulic acid	(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; caffeic acid 3-methyl ether; ferulicacid; A803063; (E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoate; CJ-00500; ZB002373; ferulate; CHEBI:29749; (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; 3-Methoxy-4-hydroxy-trans-cinnamate; (E)-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enoate; Ferulic Acid; AC1NUT2L; ferulic acid	C10H10O4	194.18	COC1=C(C=CC(=C1)C=CC(=O)O)[O-]
TCMBANKIN040448	Shengmanol xyloside			620.8 g/mol
TCMBANKIN042259	cimigenol	3779-59-7; 11-(2-Hydroxypropan-2-yl)-1,1,7a,8,13a-pentamethyloctadecahydro-5H-10,12a-epoxycyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]oxepine-2,13-diol; SCHEMBL12536213; DTXSID70634573	C31H50O4	487	C1([H])([H])C([H])([H])[C@]2([C@](C2([H])[H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@]3([H])[C@@]4(O[C@@]([H])([C@](C(C([H])([H])[H])(O[H])C([H])([H])[H])([H])C4([H])[H])C([H])([H])[C@]3(C([H]) ([H])[H])[H])[C@@]5(O[H])[H])[C@@]56C([H])([H])[H])[C@@]6([H])C([H])([H])C7([H])[H])[C@]7([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H]
TCMBANKIN044104	cimiside E		C35H54O8	603	[C@]1([H])(O[H])C([H])([H])O[C@@]([H])(O[C@]2([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]3([H])[C@@]4([C@](C4([H])[H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@]5([H])[C@@]6(O[C@]([H])(C([H])([H])[ C@@]5([H])C([H])([H])[H])[C@@]([H])(C(C([H])([H])[H])=C([H])[H])O6)[C@@]7([H])O[H])[C@]78C([H])([H])[H])[C@@]8([H])C([H])([H])C3([H])[H])C([H])([H])C2([H])[H])[C@]([H])(O[H])[C@@]1([H])O[H]
TCMBANKIN045984	cimicifugoside	AKOS032948614	C37H54O11	674.82	CC1CC2(C3C(O3)(C(O2)O)C)OC4C1C5(C(CC67CC68CCC(C(C8CC=C7C5(C4)C)(C)C)OC9C(C(C(CO9)O)O)O)OC(=O)C)C
TCMBANKIN046789	cimidahuside d		C37H56O12
TCMBANKIN047518	cimidahuside c		C37H58O12
TCMBANKIN047784	3-O-α-L-Arabinopyranosylcimigenol 15-O-β-D-glucopyranoside
TCMBANKIN058114	trans-caffeic acid	3-(3,4-dihydroxy-phenyl)-acrylic acid; caffeic acid; Caffeate; Lopac-C-0625; 71693-97-5; DivK1c_006624; KBio2_007302; (Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; NCGC00015206-02; CAS-3331-39-5; 60020_FLUKA; AI3-63211; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid polymer; (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; NSC623438; 4-(2'-Carboxyvinyl)-1,2-dihydroxybenzene; KBio2_004734; (2Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; CHEMBL1320034; AIDS-002287; AIDS002287; 501-16-6; CHEBI:36281; Prestwick1_000902; KBio1_001568; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid; AKOS000273846; OR1165; SMR000058214; Spectrum2_001612; 3,4-dihydroxycinnamate; (Z)-3-(3,4-dihydroxyphenyl)acrylic acid; Caffeicacid; KOP; AC1NO658; CCRIS 847; Caffeic acid dehydrogenation homopolymer; SPECTRUM1503987; Spectrum4_001694; SCHEMBL3682144; NCGC00017364-01; NCGC00022654-08; 4-(2-Carboxyethenyl)-1,2-dihydroxybenzene; 78734C5A-1281-44D4-B8A0-A3188AD437E3; cis-Caffeic acid; 3-(3,4-dihydroxyphenyl)acrylic acid; Cinnamic acid, 3,4-dihydroxy-; KBioGR_001988; 3,4-Dihydroxybenzeneacrylic acid; 3,4-dihydroxycinnamic acid; trans-caffeic acid; AIDS-026339; NCGC00015206-01; HSDB 7088; ZINC4482687; (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; 3-(3,4-dihydroxyphenyl)prop-2-enoate; Isocaffeic acid; SBB006475; InChI=1/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/b4-2; NCGC00017364-02; EU-0100208; C01197; MolPort-001-759-162; KBioSS_002166; Caffeic acid pure; caffeic acid ; trans-Caffeate; (2E)-3-(3,4-dihydroxyphenyl)acrylic acid; NSC 57197; (2E)-3-(3,4-Dihydroxyphenyl)-2-propenoic acid; Spectrum_001686; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, (E)-; KBio2_002166; Caffeic acid, cis-; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-; 3,4-Dihydroxybenzeneacrylate; 3-(3,4-Dihydroxy phenyl)-2-propenoic acid; 4361-87-9; 3,4-Dihydroxy-trans-cinnamate; caffeicacid; AR-360/40806927; EINECS 206-361-2; 60018_FLUKA; Caffeic acid polymer; (E)-3-(3,4-dihydroxyphenyl)acrylic acid; NCGC00022654-04; ZX-AL002121; C0625_SIGMA; SDCCGMLS-0002982.P003; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid, homopolymer; SPBio_001643; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)- (9CI); NCGC00017364-03; 3-(3,4-dihydroxyphenyl)prop-2-enoic acid; AC1LU7RL; SPBio_002943; CHEBI:16433; AIDS026339; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, homopolymer; CHEBI:17395; TNP00311; SpecPlus_000528; Prestwick0_000902; MLS000069738; 3,4-dihydroxy-cinnamic acid; 3-(3,4-Dihydroxyphenyl)propenoic acid; NCI60_004400; NSC57197; Caffeic; Lopac-C-0625; NCGC00015206-01; Caffeic acid; cis-Caffeic acid; NCGC00017364-01; (Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; C01481; 331-39-5; NCGC00015206-02; CAS-3331-39-5; 3,4-Dihydroxycinnamic acid; CHEBI:17395; (2Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; TNP00311; (Z)-3-(3,4-dihydroxyphenyl)acrylic acid; Caffeate; 1- coffee acid	C9H8O4	180.16 g/mol	C1=CC(=C(C=C1C=CC(=O)O)O)O
TCMBANKIN058164	Cimidahurine	(2S,3R,4S,5R,6R)-2-[2-hydroxy-5-(2-hydroxyethyl)phenoxy]-6-methylol-tetrahydropyran-3,4,5-triol; (2S,3R,4S,5R,6R)-2-[2-hydroxy-5-(2-hydroxyethyl)phenoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; cimidahurine; (2S,3R,4S,5R,6R)-2-[2-hydroxy-5-(2-hydroxyethyl)phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol	C14H20O8	316.3	C1=CC(=C(C=C1CCO)OC2C(C(C(C(O2)CO)O)O)O)O
TCMBANKIN058735	3-(3-methylbut-2-enylidene)oxindole	3-(3-methylbut-2-enylidene)-1H-indol-2-one; 3-(3-methylbut-2-enylidene)-2-indolinone; 3-(3-methylbut-2-enylidene)indolin-2-one;(e)-3-(3'-methyl-2'-buteny lidene)-2-indolinone;(e)-3-(3'-methyl-2'-butenylidene)-2-indolinone	C13H13NO	199.25 g/mol	CC(=CC=C1C2=CC=CC=C2NC1=O)C
TCMBANKIN059566	6-O-E-Feruloylajugol			524.57	CC1(CC(C2C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)OC(=O)C=CC4=CC(=C(C=C4)O)OC)O
TCMBANKIN059715	vitamin a		C20H30O	286.5 g/mol	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C
TCMBANKIN060435	cimiside a		C35H56O10	636.8 g/mol	CC1CC2C(OC3(C1C4(C(CC56CC57CCC(C(C7CCC6C4(C3O)C)(C)C)OC8C(C(C(CO8)O)O)O)O)C)O2)C(C)(C)O
TCMBANKIN060754	cinchotine		C19H24N2O	296.4 g/mol	CCC1CN2CCC1CC2C(C3=CC=NC4=CC=CC=C34)O
TCMBANKIN061469	isoferulic acid	4CH-004345; KBio3_001774; NSC-51987; 4FE; Spectrum3_000887; 25522-33-2; ST098721; FCH3451845; AX8011852; 537-73-5; V0307; CHEBI:27794; Bio-0194; 3-Hydroxy-4-methoxycinnamate; KBio2_004107; CS-W020120; (E)-3'-Hydroxy-4'-methoxycinnamic acid; ZINC156055; 3-Hydroxy-4-methoxycinnamic acid; BRN 2212760; M-2347; SpecPlus_000233; 2-Propenoic acid,3-(3-hydroxy-4-methoxyphenyl)-, (2E)-; C10470; SCHEMBL249041; N1393; 4-10-00-01777 (Beilstein Handbook Reference); QURCVMIEKCOAJU-HWKANZROSA-N; XSQ2K2G7MC; 3-Hydroxy-4-methoxycinnamic acid, predominantly trans, 97%; EINECS 208-676-0; Spectrum4_000979; 3-(3-Hydroxy-4-methoxyphenyl)acrylic acid; NCGC00247490-01; 3-hydroxy-4-methoxy-Cinnamate; 3-(3-Hydroxy-4-methoxyphenyl)-2-propenoic acid; AK676011; AM20040660; Isoferulate; 2-Propenoic acid, 3-(3-hydroxy-4-methoxyphenyl)-, (2E)-; 3-(3-hydroxy-4-methoxy-phenyl)acrylic acid; (E)-3-(3-hydroxy-4-methoxyphenyl)acrylic acid; AC1LEHK0; PubChem8187; ST2404733; Cinnamic acid, 3-hydroxy-4-methoxy-; 2-Hydoxy-4-methoxy-5-sulfobenzophenone; KBioSS_001539; UNII-XSQ2K2G7MC; TX-011905; 3-Hydroxy-4-methoxycinnamic acid, predominantly trans; 3-hydroxy-4-methoxy-cinnamic acid; 3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid; Z2693271860; HMS2268G06; BG01510484; SMR001215828; GTPL7980; ST5135831; 103012_ALDRICH; BBV-025077; BDBM50241245; SC-05161; (E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid; AC1Q4691; MolPort-000-490-526; (E)-3-(3-hydroxy-4-methoxy-phenyl)-acrylic acid; CI-177; isoferulic acid ; KBio2_006675; AX8329161; AC1Q5T96; MFCD00004391; EINECS 247-071-6; DivK1c_006329; Q-100609; AC1Q5RAQ; FCH089654; Hesperetic acid; 537H735; KBio1_001273; KBioGR_001357; AK-88788; MLS000563054; Hesperetate; I01-2711; bmse000618; trans-Isoferulic acid, analytical standard; (2E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid; Spectrum_001059; AKOS000141174; (E)-3-(3-hydroxy-4-methoxy-phenyl)acrylic acid; RP25302; Cinnamic acid, 3-hydroxy-4-methoxy- (8CI); STR05122; SBB042817; Isoferulasaure; MS-11465; AB0019799; D04EWW; Isoferulic acid; 3-(3-hydroxy-4-methoxy-phenyl)prop-2-enoic acid; 3-Hydroxy-4-methoxycinnamic-acid; (2E)-3-(3-Hydroxy-4-methoxyphenyl)-2-propenoic acid #; (E)-3-(3-hydroxy-4-methoxy-phenyl)prop-2-enoic acid; AC1Q4690; NSC51987; AJ-13677; KBio2_001539; Hespertitinic acid; NSC 51987; DB07109; EN300-50983; SCHEMBL249042; 2-Propenoic acid, 3-(3-hydroxy-4-methoxyphenyl)-; CHEMBL233295; KB-182983; 3-(3-hydroxy-4-methoxyphenyl)-2-Propenoate; MCULE-7013523945;hespereticacid	C10H10O4	194.18	COC1=C(C=C(C=C1)C=CC(=O)O)O
TCMBANKIN061636	cimicifugamide	isocimicifugamide	C25H31NO10	505.51	COC1=C(C=CC(=C1)CCNC(=O)C=CC2=CC(=C(C=C2)OC3C(C(C(C(O3)CO)O)O)O)OC)O

植物对应的疾病

疾病ID	病名	疾病类型	MeSH	参考文献

植物对应的靶点

靶点ID	基因名	基因别名	描述	染色体位置	Map_Location	基因类型

TCMBank_ID:

TCMBANKHE004105

ID:

TCMBANKHE004105

植物拉丁名:

Cimicifuga dahurica

功能与主治:

See Cimicifuga foetida ./See Cimicifuga foetida.

药用植物名:

兴安升麻

药用部位:

rhizome

TCM_ID_id:

7117